An outbreak of lymphogranuloma venereum has been detected following reports of the disease in Europe. “From October 2004 to the end of April 2007, 492 cases of lymphogranuloma venereum were diagnosed in the UK. These cases were predominantly in men who have sex with men and many of the patients were also infected with other STIs, particularly with HIV,” says Professor Catherine Ison from the Health Protection Agency Centre for Infections in London.
Until recently doctors saw very few cases of lymphogranuloma venereum in the UK, Europe and other developed countries. The disease is caused by certain strains of the bacterium Chlamydia trachomatis and required new diagnostic tests, that had previously not been available in the UK, before the outbreak could be detected.
Bacteria evolve all the time, and the new sexually transmitted bacterial diseases including this new variant of Chlamydia trachomatis are presenting fresh challenges in diagnosis to medical support teams.
“Microbiologists want to be more proactive in helping patients with STIs,” says Professor Ison. “We have made advances in diagnosis by using molecular tests such as the nucleic acid amplification tests (NAATs) which give us a more accurate results, faster turnaround times and can be used with non-invasive samples. These tests can be used for screening in specialised sexual health care clinics and in primary care. However they need to be carefully validated before use.”
“While the advances in technology have enabled progress in many areas, the new tests should only be used by experts who understand their advantages and disadvantages and can interpret the test results properly”, says Professor Ison. “We are very concerned that some of the new tests are being offered for sale over the internet, for home use, when they should really only be used in clinics”.
North and South Cooperation to Combat Tuberculosis
22.03.2018 | Universität Zürich
Researchers Discover New Anti-Cancer Protein
22.03.2018 | Universität Basel
An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.
The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...
In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.
Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...
Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.
They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...
A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
19.03.2018 | Event News
16.03.2018 | Event News
13.03.2018 | Event News
22.03.2018 | Trade Fair News
22.03.2018 | Earth Sciences
22.03.2018 | Earth Sciences